Covellus announces second US patent protecting its novel Modular Catheter System
October 29, 2020
NEW JERSEY--Covellus LLC. (Covellus), a medical device company focused on the development of a novel modular catheter systems for interventional procedures, received an issue notification from the United States Patent and Trademark Office for the second patent, number 10,814,120, in the Covellus patent family.
Currently, the Covellus patent family consists of four distinct specifications / invention disclosures. This patent is the first issued based on the second specification in the family. The parent patent and first specification, 10,328,250 primarily discloses embodiments of the underlying mechanical structure. The second, third and fourth specifications disclose additional applications of the modular system with enabling features. The second patent family is focused on protecting modular catheter systems with electrically active elements, such as imaging sensors and transducers, that require electrical conductors. The strategy for our claim structure can be classified in two ways:
Claims to protect the underlying mechanical structure.
Claims protecting specific enabling features for commercially valuable product embodiments with fewer limitations on the underlying mechanical structure.
“The prosecution and allowability of the new claims validate our claim strategy. We intend to use this claim strategy to create a significant patent portfolio providing long-term market exclusivity for modular catheter systems and products,” said Bradley Beach, President and CEO of Covellus.
Covellus, located in the greater New York City area, is developing the first modular catheter system for interventional procedures. Covellus has established a clear pathway for 510(k) clearance of an initial Modular Balloon System. With the Covellus Modular Balloon System, physicians have the option of using the Parent Balloon for normal Percutaneous Transluminal Angioplasty (PTA) with standard 0.035” guidewires or attach Adapter Modules to the distal end to create new unique multi-function balloon catheter. The approach is novel and poised to disrupt the PTA catheter market. Additional information about Covellus can be found at www.covellus.com
To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting FDA approvals, acceptance and demand for interventional catheter products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials, availability of additional intellectual property rights, availability of future financing sources, the regulatory environment and other risks the Company may identify from time to time in the future.